3 Questions on biosimilars in Europe: Adrian van den Hoven
biosimilars, biosimilars Europe, cancer biosimilars, Medicines for Europe
0 Comment
Adrian van den Hoven of Medicines for Europe addresses three big questions facing the biosmilars sector in Europe in 2018.